X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (760) 760
Publication (133) 133
Patent (48) 48
Book Chapter (17) 17
Government Document (4) 4
Book Review (3) 3
Conference Proceeding (3) 3
Book / eBook (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (363) 363
male (313) 313
prostate cancer (251) 251
oncology (198) 198
prostatic neoplasms - pathology (193) 193
index medicus (182) 182
animals (147) 147
metastasis (138) 138
cancer (129) 129
cell line, tumor (93) 93
mice (91) 91
prostatic neoplasms - metabolism (88) 88
article (81) 81
urology & nephrology (79) 79
prostatic neoplasms - genetics (74) 74
prostatic neoplasms - drug therapy (72) 72
expression (71) 71
middle aged (68) 68
prostate (67) 67
aged (63) 63
tumors (60) 60
cells (59) 59
cell biology (57) 57
neoplasm metastasis (57) 57
bone neoplasms - secondary (55) 55
carcinoma (54) 54
research (52) 52
tumor cells, cultured (51) 51
breast-cancer (47) 47
chemotherapy (46) 46
human necessities (43) 43
hygiene (43) 43
medical or veterinary science (43) 43
chemistry (42) 42
growth (42) 42
progression (41) 41
biochemistry & molecular biology (40) 40
metallurgy (40) 40
urology (40) 40
metastases (39) 39
preparations for medical, dental, or toilet purposes (37) 37
care and treatment (36) 36
disease progression (35) 35
research article (35) 35
aged, 80 and over (33) 33
endocrinology & metabolism (33) 33
gene expression (33) 33
in-vivo (32) 32
female (31) 31
gene expression regulation, neoplastic (31) 31
bone (30) 30
rats (30) 30
analysis (28) 28
apoptosis (28) 28
identification (28) 28
neoplasms. tumors. oncology. including cancer and carcinogens (28) 28
prostatic neoplasms - therapy (28) 28
proteins (28) 28
cell proliferation (27) 27
models, biological (27) 27
cell movement (26) 26
health aspects (26) 26
survival (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (25) 25
multidisciplinary sciences (25) 25
immunohistochemistry (24) 24
signal transduction (24) 24
specific therapeutic activity of chemical compounds ormedicinal preparations (24) 24
adenocarcinoma - drug therapy (23) 23
adult (23) 23
bone marrow (23) 23
bone metastasis (23) 23
derivatives thereof (23) 23
development and progression (23) 23
prostatic neoplasms - blood (23) 23
antineoplastic agents - therapeutic use (22) 22
mice, scid (22) 22
phenotype (22) 22
prostate-cancer (22) 22
angiogenesis (21) 21
compositions based thereon (21) 21
diagnosis (21) 21
gene (21) 21
organic macromolecular compounds (21) 21
physics (21) 21
polysaccharides (21) 21
prostate-specific antigen - blood (21) 21
their preparation or chemical working-up (21) 21
treatment outcome (21) 21
testing (20) 20
antigens (19) 19
biology (19) 19
blotting, western (19) 19
clinical trials (19) 19
gene expression profiling (19) 19
neoplasm invasiveness (19) 19
radical prostatectomy (19) 19
tumor microenvironment (19) 19
cancer research (18) 18
genetic aspects (18) 18
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (818) 818
French (23) 23
German (9) 9
Finnish (2) 2
Norwegian (2) 2
Portuguese (2) 2
Spanish (2) 2
Swedish (2) 2
Chinese (1) 1
Danish (1) 1
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Clinical Oncology, ISSN 1759-4774, 06/2018, Volume 15, Issue 6, pp. 366 - 381
Journal Article
by Robinson, Brian D and Robinson, Dan and Van Allen, Eliezer M and Wu, Yi-Mi and Schultz, Nikolaus and Lonigro, Robert J and Mosquera, Juan-Miguel and Montgomery, Bruce and Taplin, Mary-Ellen and Pritchard, Colin C and Attard, Gerhardt and Beltran, Himisha and Abida, Wassim and Bradley, Robert K and Vinson, Jake and Cao, Xuhong and Vats, Pankaj and Kunju, Lakshmi P and Hussain, Maha and Feng, Felix Y and Tomlins, Scott A and Cooney, Kathleen A and Smith, David C and Brennan, Christine and Siddiqui, Javed and Mehra, Rohit and Chen, Yu and Rathkopf, Dana E and Morris, Michael J and Solomon, Stephen B and Durack, Jeremy C and Reuter, Victor E and Gopalan, Anuradha and Gao, Jianjiong and Loda, Massimo and Lis, Rosina T and Bowden, Michaela and Balk, Stephen P and Gaviola, Glenn and Sougnez, Carrie and Gupta, Manaswi and Yu, Evan Y and Mostaghel, Elahe A and Cheng, Heather H and Mulcahy, Hyojeong and True, Lawrence D and Plymate, Stephen R and Dvinge, Heidi and Ferraldeschi, Roberta and Flohr, Penny and Miranda, Susana and Zafeiriou, Zafeiris and Tunariu, Nina and Mateo, Joaquin and Perez-Lopez, Raquel and Demichelis, Francesca and Schiffman, Marc and Nanus, David M and Tagawa, Scott T and Sigaras, Alexandros and Eng, Kenneth W and Elemento, Olivier and Sboner, Andrea and Heath, Elisabeth I and Scher, Howard I and Pienta, Kenneth J and Kantoff, Philip and de Bono, Johann S and Rubin, Mark A and Nelson, Peter S and Garraway, Levi A and Sawyers, Charles L and Chinnaiyan, Arul M
Cell, ISSN 0092-8674, 05/2015, Volume 161, Issue 5, pp. 1215 - 1228
Journal Article
1996, Cancer treatment and research, ISBN 9780792341642, Volume 88., vi, 272
Book
Cancer Research, ISSN 0008-5472, 08/2018, Volume 78, Issue 16 Supplement, pp. IA15 - IA15
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 1023 - 1023
Journal Article
Cell, ISSN 0092-8674, 07/2015, Volume 162, Issue 2, pp. 454 - 454
Journal Article
Oncotarget, ISSN 1949-2553, 2015, Volume 6, Issue 11, pp. 8491 - 8524
Journal Article
Journal of Cellular Biochemistry, ISSN 0730-2312, 04/2019, Volume 120, Issue 4, pp. 4804 - 4812
Approximately 29 000 men die of prostate cancer (PCa) each year in the United States, and 90% to 100% of them are due to incurable bone metastasis. It is... 
detection | prostate cancer | metastasis | tyramide | tumor microarray | immunofluorescence | CIRCULATING TUMOR-CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | BONE | PSA | CELL BIOLOGY | Immunohistochemistry | Autopsies | Noise reduction | Metastasis | Background noise | Tissues | Optimization | Metastases | Proteins | Amplification | Autopsy | Bone marrow | Lesions | Immunofluorescence | Prostate cancer | Prostate | Cancer | Tumors | Benchmarks
Journal Article
Nature Reviews Cancer, ISSN 1474-175X, 02/2019, Volume 19, Issue 2, pp. 110 - 117
Cell cooperation promotes many of the hallmarks of cancer via the secretion of diffusible factors that can affect cancer cells or stromal cells in the tumour... 
PUBLIC-GOODS | EVOLUTIONARY-GAME | ONCOLOGY | NATURAL-SELECTION | SOCIAL DILEMMAS | MICROENVIRONMENTAL REGULATION | GROWTH-FACTOR PRODUCTION | CLONAL EVOLUTION | DRUG-RESISTANCE | TUMOR-GROWTH | VOLUNTEERS DILEMMA | Cell interaction | Care and treatment | Research | Health aspects | Oncology, Experimental | Cancer | Secretion | Game theory | Cooperation | Stromal cells | Tumors
Journal Article
Cancer Research, ISSN 0008-5472, 08/2018, Volume 78, Issue 16 Supplement, pp. A030 - A030
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 5192 - 5192
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 365 - 365
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, p. e69239
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 2, pp. 294 - 302
Purpose Long-term (LT) androgen suppression (AS) with radiation therapy (RT) is a standard treatment of high-risk, localized prostate cancer (PCa). Radiation... 
Radiology | Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | DEPRIVATION | ORAL ETOPOSIDE | GROUP PROTOCOL 92-02 | RADIOTHERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | III TRIAL | DURATION | ESTRAMUSTINE | PACLITAXEL | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Hormonal - adverse effects | Early Termination of Clinical Trials | Neoplasm Grading | Time Factors | Chemotherapy, Adjuvant - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Adult | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Etoposide - therapeutic use | Paclitaxel - therapeutic use | Disease Progression | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Androgen Antagonists - therapeutic use | Aged | Combined Modality Therapy - methods | Estramustine - therapeutic use | Clinical trials | Radiotherapy | Health aspects | Adjuvant treatment | Radiation | Cancer | Index Medicus | PROSTATE | LUTEINIZING HORMONE | PATIENTS | NEOPLASMS | CLINICAL TRIALS | FAILURES | METASTASES | ANTIGENS | TOXICITY | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | LIBERINS | INHIBITION | DATA | HYPOTHESIS | RADIOLOGY AND NUCLEAR MEDICINE | ANDROGENS
Journal Article